Therapy News and Research

RSS

Marine snail venom may inspire new diabetes and hormone disorder treatments

Scientists are finding clues for how to treat diabetes and hormone disorders in an unexpected place: a toxin from one of the most venomous animals on the planet.

20 Aug 2024

Understanding the benefits and risks of dialysis in older patients with kidney failure

Whether dialysis is the best option for kidney failure and, if so, when to start, may deserve more careful consideration, according to a new study.

19 Aug 2024

New project aims to study the combination of two therapies for pediatric brain cancer

Natasha Sheybani, assistant professor of biomedical engineering at the University of Virginia School of Engineering, will collaborate with researchers at Children's National Hospital to study the combination of two therapies for pediatric brain cancer.

19 Aug 2024

UCSF studies point the way toward continuous care for people with Parkinson's disease

Two new studies from UC San Francisco are pointing the way toward round-the-clock personalized care for people with Parkinson's disease through an implanted device that can treat movement problems during the day and insomnia at night.

19 Aug 2024

Lecanemab effectively targets amyloid plaques in people with Down syndrome, study finds

People with Down syndrome are likely to develop Alzheimer's disease at a young age, with autopsy studies showing that by age 40 years, the brains of individuals with Down syndrome have amyloid plaques.

19 Aug 2024

Breakthrough research unveils retroelement-based aging biomarkers

Researchers at Weill Cornell Medicine and the epigenetics company TruDiagnostic have uncovered DNA markers associated with retroelements, remnants of ancient viral genetic material, in our genes that act as highly accurate epigenetic clocks predicting chronological age.

19 Aug 2024

Advancements in neoantigen vaccines offer hope for personalized cancer therapy

The saga of cancer treatment is marked by a relentless pursuit of effectiveness against a disease characterized by complexity and adaptability.

19 Aug 2024

Colorado's $100 copay cap improves diabetes medication adherence and health outcomes

Researchers examined the relationship between Colorado's $100 copayment maximum and self-expenditure, medication compliance, and health service usage for diabetes-associated comorbidities.

19 Aug 2024

New statement highlights nurses' role in managing psychosocial health after stroke

Nurses play a key role in helping patients manage emotional and social health challenges, or psychosocial health, after a stroke, and improved screening and assessment for psychosocial needs are essential to provide optimal patient care.

19 Aug 2024

Breakthrough in tissue engineering using bacteria

A research team at the Technical University of Denmark, led by Alireza Dolatshahi-Pirouz, has recently uncovered new ground in tissue engineering and cell therapy by harnessing the healing power of bacteria.

19 Aug 2024

New implantable device could revolutionize opioid overdose response

A swine model to demonstrate the potential of an implantable system for opioid safety (iSOS).

19 Aug 2024

APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

The long-term subjective cognitive decline risk associated with Herpes zoster infections.

19 Aug 2024

$Gut microbiota linked to fracture risk: Study reveals key microbial associations$

Gut microbiota linked to fracture risk: Study reveals key microbial associations

The association between gut microbiota (GM) composition and incident fractures in the Finnish Risk Monitoring Program (FINRISK) 2002 cohort.

19 Aug 2024

New RNA molecules in extracellular vesicles could transform cancer diagnosis

Scientists at the Icahn School of Medicine at Mount Sinai have identified a new class of RNAs packed into tiny particles known as extracellular vesicles (EVs) that could revolutionize how cancer and other diseases are diagnosed.

16 Aug 2024

New exosome-based drug delivery system enhances ovarian cancer treatment

Ovarian cancer is one of the most common malignancies in women worldwide. Unlike breast cancer, ovarian cancer lacks early diagnostic markers and does not show noticeable symptoms until cancer metastases, leading to a low survival rate for ovarian cancer patients.

16 Aug 2024

Ribonucleic acid for injection II enhances immunity and hematopoiesis in immunosuppressed mice

Announcing a new publication for Acta Materia Medica journal. Ribonucleic acid for injection II is a clinical adjuvant cancer therapy treatment based on immunotherapy, which exerts its effects by enhancing immune function and suppressing tumor growth.

16 Aug 2024

New target identified to combat menopause-induced obesity

A decline in estrogen during menopause causes changes in body fat distribution and associated cardiovascular and metabolic disease, but a new study identifies potential therapies that might one day reverse these unhealthy shifts.

16 Aug 2024

Researchers urge inclusion of marginalized groups to bridge bulimia nervosa treatment gaps

Researchers identified significant disparities in bulimia nervosa treatment, urging more inclusive research to address gaps in care for marginalized populations.

16 Aug 2024

Neoadjuvant immunotherapy yields comparable outcomes in high-risk liver cancer surgery

Patients with liver cancer who received immune checkpoint inhibitors (ICIs) before surgery - including those who would not have been eligible for surgery by conventional criteria - had similar outcomes to patients who received surgery upfront, according to results from a retrospective study.

15 Aug 2024

Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

Researchers at Children's Hospital of Philadelphia (CHOP), St. Jude Children's Research Hospital (St. Jude) and the Children's Oncology Group (COG) today announced a significant paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia (T-ALL), an aggressive and high-risk form of cancer, to one frequently driven by genetic changes in non-coding portions of our DNA.

14 Aug 2024

Therapy News and Research

Marine snail venom may inspire new diabetes and hormone disorder treatments

Understanding the benefits and risks of dialysis in older patients with kidney failure

New project aims to study the combination of two therapies for pediatric brain cancer

UCSF studies point the way toward continuous care for people with Parkinson's disease

Lecanemab effectively targets amyloid plaques in people with Down syndrome, study finds

Breakthrough research unveils retroelement-based aging biomarkers

Advancements in neoantigen vaccines offer hope for personalized cancer therapy

Colorado's $100 copay cap improves diabetes medication adherence and health outcomes

New statement highlights nurses' role in managing psychosocial health after stroke

Breakthrough in tissue engineering using bacteria

New implantable device could revolutionize opioid overdose response

APOE ε4 carrier status increases the long-term cognitive decline risk associated with herpes zoster

Gut microbiota linked to fracture risk: Study reveals key microbial associations

New RNA molecules in extracellular vesicles could transform cancer diagnosis

New exosome-based drug delivery system enhances ovarian cancer treatment

Ribonucleic acid for injection II enhances immunity and hematopoiesis in immunosuppressed mice

New target identified to combat menopause-induced obesity

Researchers urge inclusion of marginalized groups to bridge bulimia nervosa treatment gaps

Neoadjuvant immunotherapy yields comparable outcomes in high-risk liver cancer surgery

Study reveals a paradigm shift in the understanding of T-lineage acute lymphoblastic leukemia

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News